← Back
Data updated: Mar 10, 2026
GLAND PHARMA LTD
CardiovascularOphthalmologyInfectious Disease
GLAND PHARMA LTD is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Infectious Disease. Key products include LABETALOL HYDROCHLORIDE.
2004
Since
11
Drugs
-
Trials
123
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
KETOROLAC TROMETHAMINE 2026-01-22
Labeling
HALOPERIDOL 2025-12-18
ONDANSETRON HYDROCHLORIDE 2025-11-18
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
ONDANSETRON HYDROCHLORIDE 2025-10-23
Labeling
ONDANSETRON HYDROCHLORIDE 2025-10-23
Labeling
LABETALOL HYDROCHLORIDE 2025-10-02
LABETALOL HYDROCHLORIDE 2025-09-23
AZITHROMYCIN 2025-09-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 33%
2 drugs
Ophthalmology 17%
1 drugs
Infectious Disease 17%
1 drugs
Respiratory 17%
1 drugs
Dermatology 17%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
Novartis big-pharma
Cardiovascular, Ophthalmology, Respiratory
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Infectious Disease, Cardiovascular
Active (6)
Discontinued (4)
Company Info
- First Approval
- 2004-07-27
- Latest
- 2025-11-17
- Applications
- 17